Literature DB >> 2342605

Phorbol 12,13-dibutyrate increases vascular tone but has a dual action on intracellular calcium levels in porcine coronary arteries.

T Mori1, T Yanagisawa, N Taira.   

Abstract

The effects of phorbol 12,13-dibutyrate (PDBu). a protein kinase C activator, on the tone and intracellular calcium level (Cai2+) of vascular smooth muscles were simultaneously measured by use of a force-displacement transducer and the fura-2 microscopic fluorometric technique in porcine coronary arteries. Cumulatively applied PDBu produced a slowly developing and concentration-dependent contraction in the concentration range of 10(-8)-10(-6) mol/l. Contractions induced by PDBu were sustained after removal of PDBu. Changes in Cai2+ produced by PDBu were very slight, although Cai2+ was increased at lower concentrations (3 x 10(-8) and 10(-7) mol/l) and decreased at higher concentrations (3 x 10(-7) and 10(-6) mol/l). Verapamil 10(-6) mol/l partially inhibited the contractions throughout the concentration range of PDBu and the increase in Cai2+ induced by lower concentrations of PDBu. When the effects of PDBu were compared with those of the 90 mmol/l KCl medium, the force of contraction induced by a single concentration of 10(-7) mol/l PDBu was about 50% and the increase in Cai2+ was about 10%. Removal of extracellular calcium by 1 mmol/l EGTA decreased Cai2+ by about 20% but vascular tone did not change. PDbu (10(-7) mol/l) produced a small contraction without an increase in Cai2+ in the Ca2+-free medium. Depolarization by the 20 mmol/l KCl medium increased Cai2+ by about 20%, whereas vascular tone did not change.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342605     DOI: 10.1007/bf00169739

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

Review 1.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

2.  Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate.

Authors:  A T Chiu; J M Bozarth; M S Forsythe; P B Timmermans
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

3.  Phorbol diesters alter the contractile responses of porcine coronary artery.

Authors:  J R Miller; D J Hawkins; J N Wells
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

4.  TPA-induced contraction of isolated rabbit vascular smooth muscle.

Authors:  H Rasmussen; J Forder; I Kojima; A Scriabine
Journal:  Biochem Biophys Res Commun       Date:  1984-07-31       Impact factor: 3.575

5.  Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2.

Authors:  T Yanagisawa; M Kawada; N Taira
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

6.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

7.  Intracellular calcium levels in phorbol ester-induced contractions of vascular muscle.

Authors:  M J Jiang; K G Morgan
Journal:  Am J Physiol       Date:  1987-12

8.  Calcium dependence of phorbol 12,13-dibutyrate-induced force and myosin light chain phosphorylation in arterial smooth muscle.

Authors:  H A Singer; K M Baker
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

9.  Phorbol ester effects on neurotransmission: interaction with neurotransmitters and calcium in smooth muscle.

Authors:  J M Baraban; R J Gould; S J Peroutka; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Regulation of calcium channels in aortic muscle cells by protein kinase C activators (diacylglycerol and phorbol esters) and by peptides (vasopressin and bombesin) that stimulate phosphoinositide breakdown.

Authors:  J P Galizzi; J Qar; M Fosset; C Van Renterghem; M Lazdunski
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

View more
  9 in total

1.  Testosterone acts as a coronary vasodilator by a calcium antagonistic action.

Authors:  K M English; R D Jones; T H Jones; A H Morice; K S Channer
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

2.  Protamine relaxes vascular smooth muscle by directly reducing cytosolic free calcium concentrations in small resistance arteries.

Authors:  Takashi Akata; Kenji Kodama; Alex S Evers; Shosuke Takahashi
Journal:  J Anesth       Date:  1996-12       Impact factor: 2.078

3.  Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.

Authors:  J Kawahara; H Izumi; Y Okada; T Izawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

4.  Participation of protein kinase C in endothelin-1-induced contraction in rat aorta: studies with a new tool, calphostin C.

Authors:  H Shimamoto; Y Shimamoto; C Y Kwan; E E Daniel
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

5.  Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery.

Authors:  T Yanagisawa; T Yamagishi; Y Okada
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

6.  Characterization of endothelium-dependent relaxations resistant to nitro-L-arginine in the porcine coronary artery.

Authors:  T Nagao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

7.  BRL 38227 (levcromakalim)-induced hyperpolarization reduces the sensitivity to Ca2+ of contractile elements in canine coronary artery.

Authors:  Y Okada; T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

8.  Effects of semotiadil fumarate, a novel Ca2+ antagonist, on cytosolic Ca2+ level and force of contraction in porcine coronary arteries.

Authors:  M Kageyama; T Yanagisawa; N Taira
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

9.  Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study.

Authors:  P F Hickman; G J Kemp; C H Thompson; A J Salisbury; K Wade; A L Harris; G K Radda
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.